Acarix AB (ACIXF)
0.027
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
Acarix Enterprise Value : 29.35M for June 10, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 10, 2026 | 29.35M |
| June 09, 2026 | 29.35M |
| June 08, 2026 | 29.35M |
| June 05, 2026 | 29.35M |
| June 04, 2026 | 29.35M |
| June 03, 2026 | 29.35M |
| June 02, 2026 | 29.35M |
| June 01, 2026 | 29.35M |
| May 29, 2026 | 29.35M |
| May 28, 2026 | 29.35M |
| May 27, 2026 | 29.35M |
| May 26, 2026 | 29.35M |
| May 22, 2026 | 25.08M |
| May 21, 2026 | 25.08M |
| May 20, 2026 | 25.08M |
| May 19, 2026 | 25.08M |
| May 18, 2026 | 25.08M |
| May 15, 2026 | 25.08M |
| May 14, 2026 | 31.73M |
| May 13, 2026 | 31.73M |
| May 12, 2026 | 31.73M |
| May 11, 2026 | 31.73M |
| May 08, 2026 | 31.73M |
| May 07, 2026 | 29.35M |
| May 06, 2026 | 32.92M |
| Date | Value |
|---|---|
| May 05, 2026 | 35.29M |
| May 04, 2026 | 35.29M |
| May 01, 2026 | 32.80M |
| April 30, 2026 | 32.80M |
| April 29, 2026 | 34.10M |
| April 28, 2026 | 34.10M |
| April 27, 2026 | 44.08M |
| April 24, 2026 | 44.08M |
| April 23, 2026 | 38.85M |
| April 22, 2026 | 38.85M |
| April 21, 2026 | 38.85M |
| April 20, 2026 | 38.85M |
| April 17, 2026 | 38.85M |
| April 16, 2026 | 44.08M |
| April 15, 2026 | 44.08M |
| April 14, 2026 | 44.08M |
| April 13, 2026 | 39.65M |
| April 10, 2026 | 39.65M |
| April 09, 2026 | 31.73M |
| April 08, 2026 | 31.73M |
| April 07, 2026 | 31.73M |
| April 06, 2026 | 31.73M |
| April 02, 2026 | 31.73M |
| April 01, 2026 | 31.73M |
| March 31, 2026 | 31.73M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Elekta AB | 2.484B |
| Surgical Science Sweden AB | 134.24M |
| Senzime AB | 71.71M |
| Redsense Medical AB | 7.365M |
| Accuray, Inc. | 183.35M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.9606M |
| Revenue (Quarterly) | 0.2652M |
| Total Expenses (Quarterly) | 1.226M |
| EPS Diluted (Quarterly) | -0.0008 |
| Gross Profit Margin (Quarterly) | 54.34% |
| Profit Margin (Quarterly) | -362.2% |
| Earnings Yield | -14.81% |
| Normalized Earnings Yield | -14.81 |